Chee Conley
Insider CIK 1883804 · SYRS President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-11-18 | 2024-11-20 | 134,797 | $0.20 | $27.0K | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-10-31 | 2024-11-04 | 8,707 | $2.09 | $18.2K | 130,797 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 139,504 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2024-09-11 | 2024-09-12 | 50,000 | $1.71 | $85.5K | 122,504 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2024-09-10 | 2024-09-12 | 50,000 | $1.51 | $75.5K | 72,504 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2024-04-01 | 2024-04-02 | 3,500 | $5.12 | $17.9K | 22,504 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 23,334 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 4,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 26,004 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 14,338 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-12-02 | 2023-12-05 | 86,000 | — | $0 | 86,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-11-01 | 2023-11-02 | 6,004 | $2.22 | $13.3K | 12,338 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 17,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 18,342 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | F Tax w/h | 2023-04-03 | 2023-04-04 | 658 | $2.58 | $1.7K | 1,342 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-02-16 | 2023-02-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SYRS | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ |
| SYRS | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-09-27 | 2021-09-28 | 360,000 | — | $0 | 360,000 | SEC↗ |